Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review

SIMPLE SUMMARY: Uterine leiomyosarcoma (uLMS) is a rare and aggressive mesenchymal malignancy. Although approximately 65% of patients are diagnosed in stage I, more than 50% have relapsed disease, and effective therapies for recurrent and advanced cases are limited. This review summarizes the curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Hiroshi, Isoe, Toshiyuki, Ito, Yoichi M., Nishimoto, Naoki, Watanabe, Yudai, Yokoshiki, Saki, Watari, Hidemichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909836/
https://www.ncbi.nlm.nih.gov/pubmed/35267488
http://dx.doi.org/10.3390/cancers14051180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909836/
https://www.ncbi.nlm.nih.gov/pubmed/35267488
http://dx.doi.org/10.3390/cancers14051180

Ejemplares similares